[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"patient-engagement\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:patient-engagement":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,44,75,105,129,158,188,214],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100502797","optimizing-cardiovascular-preventive-care-for-women-following-hypertensive-disorders-of-pregnancy-100502797",false,"NCT05826925","Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy","Inclusion Criteria:\n\n* Delivered a pregnancy complicated by a hypertensive disorder of pregnancy at the University of Utah during the current hospital admission\n* Ability to speak and read English or Spanish\n* Written informed consent obtained\n\nExclusion Criteria:\n\n* Cardiovascular disease diagnosis (history of peripheral artery disease, stroke, or myocardial infarction)\n* Impairment of cognitive function or vision that prohibits communication and\u002For reading the decision aid.",true,"FEMALE","18 Years",{"count":19,"type":20},30,"ESTIMATED","INTERVENTIONAL",[23],"NA","Cardiovascular disease is the leading cause of death among women in the United States, and women with hypertensive disorders of pregnancy have a 2-fold higher risk for cardiovascular disease later in life compared to women with uncomplicated pregnancies. This research investigates a patient-centered intervention during the postpartum period to promote engagement in cardiovascular preventive care.",[26,27,28,29,30],"Hypertension, Pregnancy Induced","Hypertension Complicating Pregnancy","Preeclampsia","Cardiovascular Diseases","Patient Engagement","RECRUITING","2026-06-22",{"date":34,"type":35},"2026-06-23","ACTUAL",{"date":37,"type":20},"2026-07-15",{"date":39,"type":20},"2027-08",{"name":41,"class":42},"University of Utah","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":51,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":21,"phases":56,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":74},"100495559","mobile-video-directly-observed-therapy-dot-for-immunosuppression-medication-adherence-in-adolescent-heart-transplant-recipients-100495559","NCT05732779","Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients","Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients: Enhancing Technological Innovation and Strengthening the Role of Small Businesses in Meeting Needs of Adolescent Organ Transplant","Inclusion Criteria:\n\n* Eligible participants are 10-21 years of age\n* Have received a heart transplant and are followed participating pediatric heart transplant centers\n* English-speaking or Spanish-speaking\n* Own a smart-phone or have access to the mobile app through other devices\n* Are willing to receive information through it\n* Have a MLVI score of greater than 2.0 over the last year\n\nExclusion Criteria:\n\n• Those with cognitive impairments will not be eligible for enrollment due to inability to provide informed assent","ALL","10 Years","21 Years",{"count":55,"type":20},100,[23],"We will conduct a two-group randomized controlled trial to examine the eMocha DOT intervention with pediatric HT recipients.In this population, medication nonadherence remains a primary cause of late acute rejection (LAR) episodes, increased number of hospitalizations, graft failure, and patient mortality. Herein, we propose an innovative approach to promote medication adherence and improve patient and graft outcomes.",[59,60,61,62,63,64,30],"Heart Transplant Rejection","Immune Suppression","Pediatric Heart Transplant","Medication Nonadherence","Health Behavior","Remote Monitoring","2026-02-24",{"date":67,"type":35},"2026-02-27",{"date":69,"type":35},"2024-10-01",{"date":71,"type":20},"2027-05-01",{"name":73,"class":42},"University of Florida",4,{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":83,"targetDuration":4,"studyType":21,"phases":85,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":103,"locationsCount":43},"100515282","at-home-breast-oncology-care-delivered-with-e-health-solutions-100515282","NCT05989477","At-home Breast Oncology Care Delivered With E-health Solutions","At-home Breast Oncology Care Delivered With E-health Solutions The ABODE Study","ABODE","Inclusion Criteria:\n\n* Females (assigned female at birth)\\*\n* Diagnosed with first, primary invasive BC\n* Must have surgery as their first step in treatment pathway\n* Age≥18\n* Access to an electronic device with connection to the internet\n* A valid email address\n* Can communicate in English \\*Since BC risk is sex-related and based on physiological values, our inclusion criteria are based on sex (not gender)\n\nExclusion criteria:\n\n* Males (assigned male at birth), as BC surgical treatment options and experiences are different\n* Diagnosed with non-operable breast cancer\n* Stage 4\u002Fmetastatic (whether determined at diagnosis or during surgery)\n* Those with hearing or visual challenges\n* Neo-adjuvant chemotherapy\n* Should not be enrolled in any other UHN study using an e-Health application\n* Breast cancer surgery is scheduled for less 5 business days after enrollment",{"count":84,"type":20},200,[23],"The COVID-19 pandemic has significantly impacted healthcare service delivery, highlighting the need for high quality virtual patient care. Our team has developed a multi-dimensional remote eHealth solution for newly diagnosed breast cancer patients and their practitioners to use during the diagnostic and follow-up period. The ABODE study involved development of a Breast Cancer Treatment Application (app) which will facilitate virtual consultations, deliver patient education material, and collect patient reported outcome measures (PROMs). Using a randomized controlled trial design, the team will evaluate a variety of outcomes for breast cancer patients who will use the app throughout their diagnosis and treatment period.\n\nPrimary Objective: To compare changes in patient activation (assessed by PAM-13) over 1 year among newly diagnosed breast cancer patients between those using the app and those receiving standard care.\n\nSecondary Objectives:\n\n1. Compare additional PROMs between the standard care and intervention groups\n2. Describe health service outcomes among app users\n3. Explore end-user experience of using the app\n4. Measure activity levels using wearable devices",[30,88,89],"Patient Activation","Patient Reported Outcome Measures",[91,92,93,94,95,96],"e-Health","m-Health","Mobile Application","Psychosocial Oncology","Survivorship","Breast Cancer","2025-04-11",{"date":99,"type":35},"2025-04-16",{"date":101,"type":35},"2023-06-22",{"date":32,"type":20},{"name":104,"class":42},"University Health Network, Toronto",{"id":106,"slug":107,"hasResults":11,"nctId":108,"briefTitle":109,"officialTitle":110,"acronym":111,"eligibilityCriteria":112,"healthyVolunteers":11,"sex":51,"minAge":17,"maxAge":4,"enrollmentInfo":113,"targetDuration":4,"studyType":21,"phases":115,"briefSummary":116,"conditions":117,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":43},"100574163","patient-engagement-in-ptsd-treatment-pep-100574163","NCT06755710","Patient Engagement in PTSD Treatment (PEP)","Patient Engagement in PTSD Treatment (PEP) - Advancing PTSD Treatment Outcomes","PEP","In- and exclusion criteria of the randomised controlled trial for Psychotherapeutic Unit\n\nInclusion Criteria:\n\n* Adults (18 years or older)\n* PTSD pursuant to the ICD-10 research criteria\n* Signed informed consent\n* patients referred to \"Main Level\" treatment\n\nExclusion Criteria:\n\n* Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F31.9). Participants are excluded only if the psychotic experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and\u002For depression.\n* Dependence syndrome of drugs or alcohol: Active dependence and use (F1x.24-F1x.26).\n\nIn- and exclusion criteria of the randomised controlled trial for Competencecenter of Transcultural Psychiatry:\n\nInclusion criteria:\n\n* Adult (18 years or older)\n* Refugees or persons who have been family reunified with a refugee\n* PTSD pursuant to the ICD-10 research criteria\n* Psychological trauma experienced outside Denmark in the anamnesis. Trauma is imprisonment or detention with torture (according to the United Nations' definition of torture) or acts of cruel, inhuman and degrading treatment or punishment. Trauma can also be organised violence, long-term political persecution and harassment, or war and civil war experiences.\n* Signed informed consent\n\nExclusion criteria:\n\n* Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F31.9). Participants are excluded only if the psychotic experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and\u002For depression.\n* Dependence syndrome of drugs or alcohol: Active dependence and use (F1x.24-F1x.26).",{"count":114,"type":20},427,[23],"The goal of this clinical study is to improve the outcome of outpatient PTSD treatment at two clinics treating majority ethnic Danes and refugees with PTSD respectively. The study will consist of two similar randomized controlled trials.\n\nThe main questions the study aims to answer are:\n\n* Does an added motivation enhancement module as a precursor for PTSD treatment reduce dropout and increase treatment outcome?\n* Does an added Shared Decision-Making session which facilitate individualized treatment yield a superior outcome compared to PTSD treatment and PTSD treatment supplemented by motivation enhancement?\n\nParticipants are recruited at two different clinics, Psychotherapeutic Unit (PU) and Competence Centre for Transcultural Psychiatry (CTP). At PU the participants are randomized to one of two arms, and at CTP to one of three arms. One arm is the control group where participants will receive treatment as usual (TAU), one arm is the first intervention group where the participants will receive an Introductory PTSD module consisting of four sessions focusing on enhancing motivation for PTSD treatment, before continuing in TAU. The last arm is the second intervention group, which will only take place at CTP. Here the patient will receive the Introductory PTSD module followed by a session of Shared Decision Making, where the participant together with the MD decides which of four standardized treatment courses they will receive.\n\nThe treatment for all patients will last between 8-13 months.",[118,119,30],"PTSD","Depression Disorders","2025-04-08",{"date":122,"type":35},"2025-04-09",{"date":124,"type":35},"2025-01-02",{"date":126,"type":20},"2028-08-31",{"name":128,"class":42},"Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital",{"id":130,"slug":131,"hasResults":11,"nctId":132,"briefTitle":133,"officialTitle":134,"acronym":4,"eligibilityCriteria":135,"healthyVolunteers":11,"sex":51,"minAge":17,"maxAge":136,"enrollmentInfo":137,"targetDuration":4,"studyType":21,"phases":139,"briefSummary":140,"conditions":141,"keywords":143,"overallStatus":148,"whyStopped":4,"lastUpdateSubmitDate":149,"lastUpdatePostDateStruct":150,"startDateStruct":152,"completionDateStruct":154,"leadSponsor":156,"locationsCount":43},"100565515","use-of-back-support-after-transfemoral-angiography-100565515","NCT06643182","Use of Back Support After Transfemoral Angiography","Effect of Back Support on Vital Signs and Comfort After Transfemoral Angiography","Inclusion Criteria:\n\n* Adult patients over the age of 18 who underwent femoral coronary angiography,\n* Patients who did not have verbal communication problems,\n* Patients who consented to participate in the study were determined as patients.\n\nExclusion Criteria:\n\n* Patients who underwent radial angiography,\n* Have chronic low back pain,\n* Have had previous back surgery\u002Fherniated disc,\n* Have coagulation problems (PLT\\\u003C50000 mm3),\n* Did not consent to participate in the study,\n* Have communication problems.","90 Years",{"count":138,"type":20},80,[23],"In the routine treatment procedure after coronary angiography (CAG), the patients remain in the supine position for a long time, which leads to decreased venous return and back pain. In addition, lying in the same position for 2 hours or more in the back area causes an increase in pressure. Increased pressure disrupts cell and tissue blood supply. The resulting pain may increase sympathetic stimulation. Therefore, sympathetic stimulation increases heart rate, blood pressure, myocardial oxygen consumption and cardiac workload. After the transfemoral coronary angiography (CAG) procedure, which is frequently applied to adults for both diagnosis and treatment, the back support to be applied to ensure that the vital signs (pulse, blood pressure, respiratory rate and blood oxygen saturation) of the patients remain stable and to increase their comfort level can prevent the deviation of the vital signs of the patients from normal and contribute to the treatment process with patient satisfaction.",[30,142],"Femoral Angiography",[144,145,146,147],"femoral angiography","back support","vital signs","comfort","NOT_YET_RECRUITING","2024-10-14",{"date":151,"type":35},"2024-10-16",{"date":153,"type":20},"2024-11-01",{"date":155,"type":20},"2025-09-01",{"name":157,"class":42},"Inonu University",{"id":159,"slug":160,"hasResults":11,"nctId":161,"briefTitle":162,"officialTitle":162,"acronym":163,"eligibilityCriteria":164,"healthyVolunteers":11,"sex":51,"minAge":53,"maxAge":4,"enrollmentInfo":165,"targetDuration":4,"studyType":21,"phases":167,"briefSummary":168,"conditions":169,"keywords":174,"overallStatus":148,"whyStopped":4,"lastUpdateSubmitDate":178,"lastUpdatePostDateStruct":179,"startDateStruct":181,"completionDateStruct":183,"leadSponsor":185,"locationsCount":187},"100561973","ai-augmented-motivational-interviewing-training-for-primary-care-100561973","NCT06597123","AI-Augmented Motivational Interviewing Training for Primary Care","AIM-PC","Inclusion Criteria:\n\n* Primary care providers (physicians, physician assistants, and nurse practitioners) employed in primary care practices of the Premier Physician Network of Premier Health (southwest Ohio) are eligible to participate.\n\nExclusion Criteria:\n\n* Eligible PCPs who opt to not provide informed consent for participation will be excluded from the study.",{"count":166,"type":20},150,[23],"This study will examine the impact of training primary care providers (PCPs) in motivational interviewing (MI) using artificial intelligence (AI) to augment the training process. MI is a patient-centered approach to engaging patients in their own care. There will be a control group and two intervention groups, with the intervention groups receiving a different amount of MI training. The hypothesis is that the AI-augmented MI training will result in improved patient outcomes, improved clinician wellbeing, and reduced behavioral manifestation of clinician biases. This mixed-methods project will also collect qualitative data from structured interviews and focus groups with participating PCPs to examine perceived facilitators and barriers to the use of the MI approach in primary care.",[170,30,171,172,173],"Multiple Chronic Conditions","Burnout, Professional","Motivational Interviewing","Implicit Bias",[172,175,170,176,177,30],"Artificial Intelligence","Clinician Wellbeing","Biases","2024-09-12",{"date":180,"type":35},"2024-09-19",{"date":182,"type":20},"2025-07-01",{"date":184,"type":20},"2028-06-30",{"name":186,"class":42},"Wright State University",2,{"id":189,"slug":190,"hasResults":11,"nctId":191,"briefTitle":192,"officialTitle":193,"acronym":194,"eligibilityCriteria":195,"healthyVolunteers":15,"sex":16,"minAge":196,"maxAge":197,"enrollmentInfo":198,"targetDuration":4,"studyType":21,"phases":200,"briefSummary":201,"conditions":202,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":205,"lastUpdatePostDateStruct":206,"startDateStruct":208,"completionDateStruct":210,"leadSponsor":212,"locationsCount":43},"100467365","melanated-group-midwifery-care-mgmc-100467365","NCT05365815","Melanated Group Midwifery Care (MGMC)","Black Midwives for Black Women: Maternity Care to Improve Trust and Attenuate Structural Racism","MGMC","Inclusion criteria for patients:\n\n* pregnant women who self-identify as Black on a standard prenatal intake form\n* less than 20 weeks pregnant\n* 15 years old or older\n* present to the general obstetrics group at the University of Chicago Medical Center for their new prenatal visit\n* speak and understand English\n\nInclusion criteria for providers:\n\n• All black midwives, care coordinators, and community postpartum doulas at the University of Chicago are eligible to participate.\n\nExclusion criteria for patients:\n\n* having a condition for which they present to a higher level of obstetrics care (e.g., maternal fetal medicine) for their new prenatal visit\n* having a cognitive issue that impairs their ability to give informed consent.","15 Years","49 Years",{"count":199,"type":20},432,[23],"This study is being conducted to determine if a multi-level intervention for delivering maternity care can improve patient trust and engagement among Black birthing people.",[203,204,30],"Pregnancy Complications","Maternal Care Patterns","2024-07-01",{"date":207,"type":35},"2024-07-03",{"date":209,"type":35},"2022-06-08",{"date":211,"type":20},"2027-02-01",{"name":213,"class":42},"University of Illinois at Chicago",{"id":215,"slug":216,"hasResults":11,"nctId":217,"briefTitle":218,"officialTitle":218,"acronym":4,"eligibilityCriteria":219,"healthyVolunteers":15,"sex":51,"minAge":17,"maxAge":4,"enrollmentInfo":220,"targetDuration":4,"studyType":21,"phases":222,"briefSummary":223,"conditions":224,"keywords":226,"overallStatus":148,"whyStopped":4,"lastUpdateSubmitDate":229,"lastUpdatePostDateStruct":230,"startDateStruct":232,"completionDateStruct":234,"leadSponsor":236,"locationsCount":4},"100524619","testing-design-thinking-methodology-to-engage-hispanic-and-latino-families-of-autistic-children-in-research-100524619","NCT06111092","Testing Design Thinking Methodology to Engage Hispanic and Latino Families of Autistic Children in Research.","Inclusion Criteria:\n\n* Autistic person:\n\n  * confirmed diagnosis of autism spectrum disorder\n  * Hispanic\u002FLatino\n  * received therapeutic services as a child; and\n  * willing and able (with i.e., language and cognitive skills) to participate in the design thinking or focus group session designed to learn about the facilitator and barriers to receipt of therapeutic services.\n* Parent\u002Fcaregiver:\n\n  * Hispanic\u002FLatino caregiver of an autistic child who receives or received therapeutic services such as occupational, physical, speech and language therapy\n  * willing to participate in the design thinking or focus group session designed to learn about the facilitator and barriers to receipt of therapeutic services.\n* Exclusion Criteria:\n\n  * Do not meet age for autistic individual or diagnostic criteria",{"count":221,"type":20},186,[23],"The goal of this study is to compare the level of engagement in the Hispanic and Latino parents of autistic children and culturally adapt the protocol of Ayres Sensory Integration to improve participation and health outcomes.\n\nThe main questions it aims to answer are:\n\nDoes the Design Thinking process result in higher stakeholder engagement and satisfaction in the research process in comparison to Focus Groups? Secondary question: Do cultural adaption using DT data yield higher scores of acceptability and implementation feasibility in comparison to FG methods?\n\nParticipants will:\n\n* Be randomized into two groups of engagement (focus groups and design thinking)\n* Be blinded (clinicians, selected caregivers, autistic persons, and cultural experts) and will rate the acceptability, feasibility, and cultural appropriateness of the protocol based on DT data higher than the protocol based on FG data.",[225,30],"Autism Spectrum Disorder",[227,228],"Autism","Patient engagement","2023-10-31",{"date":231,"type":35},"2023-11-02",{"date":233,"type":20},"2024-02-01",{"date":235,"type":20},"2026-11-30",{"name":237,"class":42},"Thomas Jefferson University"]